Cargando…
Cell engineering techniques improve pharmacology of cellular therapeutics
Despite the rapid growth of clinical trials for cellular therapy worldwide, their clinical success is still afflicted with formidable challenges demanding conceptual and technological overhaul. Pharmacology, which is conventionally divided into pharmacokinetics (PK) and pharmacodynamics (PD) in drug...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934495/ https://www.ncbi.nlm.nih.gov/pubmed/36824659 http://dx.doi.org/10.1016/j.bbiosy.2021.100016 |
_version_ | 1784889899804000256 |
---|---|
author | Liang, Kaini Du, Yanan |
author_facet | Liang, Kaini Du, Yanan |
author_sort | Liang, Kaini |
collection | PubMed |
description | Despite the rapid growth of clinical trials for cellular therapy worldwide, their clinical success is still afflicted with formidable challenges demanding conceptual and technological overhaul. Pharmacology, which is conventionally divided into pharmacokinetics (PK) and pharmacodynamics (PD) in drug discovery have emerged as a prominent research direction to elucidate the cell fate and ensure the efficacy and safety of the therapeutic cells. Herein, we concisely present the dilemmas of cellular therapies, the concept of cell pharmacology, and the advances in cell engineering that leverage the cell formulation technologies to modulate cellular PK/PD for development of more cogent and versatile cell-based therapies. |
format | Online Article Text |
id | pubmed-9934495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99344952023-02-22 Cell engineering techniques improve pharmacology of cellular therapeutics Liang, Kaini Du, Yanan Biomater Biosyst VSI: Leading Opinion Paper Despite the rapid growth of clinical trials for cellular therapy worldwide, their clinical success is still afflicted with formidable challenges demanding conceptual and technological overhaul. Pharmacology, which is conventionally divided into pharmacokinetics (PK) and pharmacodynamics (PD) in drug discovery have emerged as a prominent research direction to elucidate the cell fate and ensure the efficacy and safety of the therapeutic cells. Herein, we concisely present the dilemmas of cellular therapies, the concept of cell pharmacology, and the advances in cell engineering that leverage the cell formulation technologies to modulate cellular PK/PD for development of more cogent and versatile cell-based therapies. Elsevier 2021-04-08 /pmc/articles/PMC9934495/ /pubmed/36824659 http://dx.doi.org/10.1016/j.bbiosy.2021.100016 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | VSI: Leading Opinion Paper Liang, Kaini Du, Yanan Cell engineering techniques improve pharmacology of cellular therapeutics |
title | Cell engineering techniques improve pharmacology of cellular therapeutics |
title_full | Cell engineering techniques improve pharmacology of cellular therapeutics |
title_fullStr | Cell engineering techniques improve pharmacology of cellular therapeutics |
title_full_unstemmed | Cell engineering techniques improve pharmacology of cellular therapeutics |
title_short | Cell engineering techniques improve pharmacology of cellular therapeutics |
title_sort | cell engineering techniques improve pharmacology of cellular therapeutics |
topic | VSI: Leading Opinion Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934495/ https://www.ncbi.nlm.nih.gov/pubmed/36824659 http://dx.doi.org/10.1016/j.bbiosy.2021.100016 |
work_keys_str_mv | AT liangkaini cellengineeringtechniquesimprovepharmacologyofcellulartherapeutics AT duyanan cellengineeringtechniquesimprovepharmacologyofcellulartherapeutics |